What's in Sylentis, S.A.'s pipeline?

Sylentis, S.A. has 9 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 3 in Phase 2, 4 in Phase 1.

Which companies overlap with Sylentis, S.A.'s portfolio?

Top competitors by shared drug class: Acerta Pharma BV, Avidity Biosciences, Inc., Hoffmann-La Roche, Ionis Pharmaceuticals, Inc., Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sylentis-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Sylentis, S.A. — Portfolio Competitive Intelligence Brief

Sylentis, S.A. pipeline: 0 marketed, 0 filed, 2 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 3 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tivanisiran sodium ophthalmic solution	Tivanisiran sodium ophthalmic solution	phase 3	antisense oligonucleotide	SOD1 gene	Ophthalmology
SYL1001 ophthalmic solution	SYL1001 ophthalmic solution	phase 3	siRNA (small interfering RNA)	TGF-β2 (transforming growth factor-beta 2)	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Acerta Pharma BV · 1 shared drug class
Avidity Biosciences, Inc. · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Ionis Pharmaceuticals, Inc. · 1 shared drug class
Pfizer · 1 shared drug class
Supernus Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sylentis, S.A.:

Cite this brief

Drug Landscape (2026). Sylentis, S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sylentis-s-a. Accessed 2026-05-16.